Cargando…

No evidence of resistance to itraconazole in a prospective real-world trial of dermatomycosis in India

BACKGROUND: The prevalence of superficial fungal infections in India is believed to have increased substantially in the past decade. We evaluated the treatment outcomes and risk factors associated with clinical response to a treatment course of itraconazole for the management of dermatomycosis in In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Handa, S., Villasis-Keever, A., Shenoy, M., Anandan, S., Bhrushundi, M., Garodia, N., Fife, D., De Doncker, P., Shalayda, K., Hu, P., Fonseca, S., Cure-bolt, N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928099/ https://www.ncbi.nlm.nih.gov/pubmed/36787305 http://dx.doi.org/10.1371/journal.pone.0281514

Ejemplares similares

Dermatomycosis Frequency and Localization Sites
por: Koçinaj, Allma Ferizi, et al.
Publicado: (2015)

Epidemiological Characterization of Dermatomycosis in Ethiopia
por: Araya, Shambel, et al.
Publicado: (2021)

Studies on the Relationship of Dermatomycosis to Ulceration and Gangrene of the Extremities
por: Thompson, Kenneth W.
Publicado: (1944)

In Vitro Antifungal Activity of Hexahydropyrimidine Derivatives against the Causative Agents of Dermatomycosis
por: Martins, Francislene J., et al.
Publicado: (2017)

An Open-Label, Randomized, Double-Arm Clinical Trial to Compare the Effectiveness and Safety of Super Bioavailable Itraconazole Capsules and Itraconazole Capsules in the Management of Dermatophytosis in India
por: Shenoy, Manjunath, et al.
Publicado: (2021)

Risk of retinal detachment and exposure to fluoroquinolones, common antibiotics, and febrile illness using a self-controlled case series study design: Retrospective analyses of three large healthcare databases in the US
por: Londhe, Ajit A., et al.
Publicado: (2022)

White-nose syndrome: A novel dermatomycosis of biologic interest and epidemiologic consequence
por: Magnino, Michele Z., et al.
Publicado: (2020)

Development of a Clioquinol Nanocarrier as a New, Promising Option for the Treatment of Dermatomycosis
por: Jacobus Berlitz, Simone, et al.
Publicado: (2023)

Real-World Assessment of Renal and Bone Safety among Patients with HIV Infection Exposed to Tenofovir Disoproxil Fumarate-Containing Single-Tablet Regimens
por: Nkhoma, Ella T., et al.
Publicado: (2016)

Cutaneous dermatomycosis with concurrent Paecilomyces lilacinus and Candida guilliermondii in a patient with longstanding diabetes
por: Kam, Sharon, et al.
Publicado: (2021)

Evaluation of disability in patients exposed to fluoroquinolones
por: Wilcox, Marsha A., et al.
Publicado: (2020)

Beads and Beyond: An Observational Study to Generate Real World Evidence on Various Brands of Itraconazole
por: Kar, Debjit, et al.
Publicado: (2022)

SIXTEEN YEARS OF DERMATOMYCOSIS CAUSED BY Candida spp. IN THE METROPOLITAN AREA OF PORTO ALEGRE, SOUTHERN BRAZIL
por: HEIDRICH, Daiane, et al.
Publicado: (2016)

Skin Mycobiota of the Captive Giant Panda (Ailuropoda melanoleuca) and the Distribution of Opportunistic Dermatomycosis-Associated Fungi in Different Seasons
por: Ma, Xiaoping, et al.
Publicado: (2021)

No Evidence of an Association Between Efavirenz Exposure and Suicidality Among HIV Patients Initiating Antiretroviral Therapy in a Retrospective Cohort Study of Real World Data
por: Nkhoma, Ella T., et al.
Publicado: (2016)

Microsporidial Stromal Keratitis: Successful Treatment with Topical Voriconazole and Oral Itraconazole
por: Coca, Mircea, et al.
Publicado: (2016)

Tamjanika, a Balkan native variety of Vitis vinifera L.: Chemical characterization, antibacterial, and anti‐dermatomycosis potential of seed oil
por: Đorđevski, Nikoleta, et al.
Publicado: (2022)

Efficacy of Super-Bioavailable Itraconazole and Conventional Itraconazole at Different Dosing Regimens in Glabrous Tinea Infection - A Randomized Clinical Trial
por: Shenoy, Manjunath M, et al.
Publicado: (2023)

Repurposing antifungals: population pharmacokinetics of itraconazole and hydroxy-itraconazole following administration of a nanocrystal formulation
por: Jansen, Anouk M E, et al.
Publicado: (2023)

A severe case of Trichophyton rubrum-caused dermatomycosis exacerbated after COVID-19 vaccination that had to be differentiated from pustular psoriasis
por: Norimatsu, Yuta, et al.
Publicado: (2022)

Real-World Epidemiology, Clinical and Economic Burden of Chronic Hepatitis B in Japan: A Retrospective Study Using JMDC Claims Database
por: Umemura, Takeji, et al.
Publicado: (2023)

Pharmacokinetic and clinical comparison of super-bioavailable itraconazole and conventional itraconazole at different dosing in dermatophytosis
por: Dhoot, Dhiraj, et al.
Publicado: (2023)

Risk of aortic aneurysm and dissection following exposure to fluoroquinolones, common antibiotics, and febrile illness using a self-controlled case series study design: Retrospective analyses of three large healthcare databases in the US
por: Londhe, Ajit A., et al.
Publicado: (2021)

Heart failure induced by itraconazole
por: Okuyan, Hızır, et al.
Publicado: (2013)

475. Does Metabolite Matter? Defining Target Itraconazole and Hydroxy-itraconazole Serum Levels for Blastomycosis
por: Hess, Danielle, et al.
Publicado: (2022)

ITS rDNA Gene Analysis Versus MALDI-TOF MS For Identification of Neoscytalidium dimidiatum Isolated from Onychomycosis and Dermatomycosis Cases in Medellin (Colombia)
por: Flórez-Muñoz, Sindy V., et al.
Publicado: (2019)

A META-ANALYSIS COMPARING EFFICACY OF CONTINUOUS TERBINAFINE WITH INTERMITTENT ITRACONAZOLE FOR TOENAIL ONYCHOMYCOSIS
por: Trivedi, N A, et al.
Publicado: (2010)

The Many Faces of Itraconazole Cardiac Toxicity
por: Teaford, Hilary R., et al.
Publicado: (2020)

Una década de Observatorios Urbanos: los nuevos retos
por: Villasís Keever, Ricardo, et al.
Publicado: (2018)

The Antifungal Itraconazole Is a Potent Inhibitor of Chikungunya Virus Replication
por: Policastro, Lucca R., et al.
Publicado: (2022)

Functional Nanocarriers for Delivering Itraconazole Against Fungal Intracellular Infections
por: Mejía, Susana P., et al.
Publicado: (2021)

Tacrolimus Increases the Effectiveness of Itraconazole and Fluconazole against Sporothrix spp.
por: Borba-Santos, Luana P., et al.
Publicado: (2017)

Conducting real-world evidence studies in India
por: Bhatt, Arun
Publicado: (2019)

Candidiasis vulvovaginal tratamiento oral con itraconazol/
por: Rodriguez Serrano, Tiburcio Manuel
Publicado: (1993)

ORAL ITRACONAZOLE FOR THE TREATMENT OF SEVERE SEBORRHOEIC DERMATITIS
por: Das, Jayasri, et al.
Publicado: (2011)

Investigation of microemulsion system for transdermal delivery of itraconazole
por: Chudasama, Arpan, et al.
Publicado: (2011)

Effect of Itraconazole on the Pharmacokinetics of Diclofenac in Beagle Dogs
por: Al-Jenoobi, Fahad I.
Publicado: (2010)

Transcriptional profile of Paracoccidioides spp. in response to itraconazole
por: Neto, Benedito Rodrigues da Silva, et al.
Publicado: (2014)

Comparison between Itraconazole and Cotrimoxazole in the Treatment of Paracoccidiodomycosis
por: Cavalcante, Ricardo de Souza, et al.
Publicado: (2014)

Skin rash during treatment with generic itraconazole
por: De Vuono, Antonio, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_acid9h5igiea014ljagnbe6gfs